P-MSC/TERT308 as model to optimize cellular cytotoxicity assays
P-MSC/TERT308 as model to optimize cellular cytotoxicity assay May 27th, 2025, Vienna, AustriaWe are pleased to share a new research note from partners
By Giulia Corso|2025-05-27T07:00:07+00:00May 27th, 2025|EU funded project, LifeSaver Project, Maternal and fetal health, mesenchymal stromal cells, telomerized cells|
P-MSC/TERT308 as model to optimize cellular cytotoxicity assay May 27th, 2025, Vienna, AustriaWe are pleased to share a new research note from partners
By Giulia Corso|2022-11-30T10:09:00+00:00November 30th, 2022|Maternal and fetal health|
The LifeSaver project film November 30, 2022, Vienna, Austria Evercyte is a proud participant in the LifeSaver Project
By Evercyte|2021-11-25T20:37:23+00:00November 25th, 2021|Maternal and fetal health|
We are proud to announce our participation in the LIVESAVER project November 25, 2021, Vienna, Austria The LIFESAVER project addresses the